I don't mean to be a naysayer, but this has been said for a long time now. We need to just keep watching to see what Management is going to do. I truly hope and the keyword is hope that they can start (1) selling Excellegan to the VA, other hospitals and other countries as planned, (2), their cancer research takes off. (3) IPO / IND happens - we will see.

Until we see the management put out any info on any of these, I don't think we see the PPS go up, unless someone decides to start buying with confidence, which I am still waiting on.

Again, they have the science. the products, that is not even up to debate. It's how they use it. I am also surprised that no company has even come forward or maybe they have and offered to buy them out as it's cheaper to own the science overall than reinvent the wheel and a lot of companies have 4 - 5 billion at least to spend on the science the Generec / Nugenerex has going for them overall.

.12 - 13 is simply way to low for this company with the technology and products that is has. But we will see.